The short answer
BPC-157 is C62H98N16O22 at 1419.5 Da: fifteen residues, net negatively charged, readily water-soluble, with a rigid polyproline segment hinged by flexible glycines. It carries none of the residues that normally dictate peptide handling.
Key facts
- Formula
- C62H98N16O22
- Molecular weight
- 1419.5 Da
- Net charge
- Negative at physiological pH
- Solubility
- Readily water-soluble
- Conformation
- Rigid proline runs, flexible glycine hinges
- Absent
- Cysteine, methionine, aromatics
Charge and solubility
Three acidic residues against one basic gives a net negative charge at physiological pH. Combined with the absence of any substantial hydrophobic patch (leucine and valine at the C-terminus are the only markedly hydrophobic residues), the peptide is strongly hydrophilic and dissolves readily in aqueous buffer.
A mixed conformational architecture
This is what distinguishes BPC-157 physically from the flexible heptapeptides elsewhere in this library. Three consecutive prolines form a locked, extended polyproline segment; glycines at 1, 6 and 13 provide flexibility around it. The molecule is neither a rigid rod nor a random coil but something in between, with defined and undefined regions.
Research material referenced
BPC-157 5mg, third-party HPLC tested
Why that might matter functionally
A partially structured peptide pays a smaller entropic penalty on binding than a fully flexible one, because some of its conformational freedom is already constrained. Whether that is relevant to BPC-157's reported activity is unknown (no receptor is established), but it is a real structural difference from a peptide of comparable size with no proline.
The absent liabilities
No cysteine means no disulfide chemistry. No methionine means no thioether oxidation. No asparagine adjacent to glycine means the classic deamidation hotspot is absent, though aspartate-glycine at positions 11 to 13 deserves mention as a site where aspartate-related rearrangement can occur in some sequences.
The analytical inconvenience
No aromatic residue means no absorbance near 280 nm and no spectrophotometric quantification. Concentration must be established gravimetrically from a certified peptide content, or by another analytical route. This recurs across several categories in this library and is a real practical nuisance rather than a technicality.
Quick reference
| Property | Value |
|---|---|
| Sequence | GEPPPGKPADDAGLV |
| Molecular weight | 1419.5 Da |
| Formula | C62H98N16O22 |
| CAS | 137525-51-0 |
| PubChem CID | 9941957 |
| UNII | 8ED8NXK95P |
Frequently asked questions
Is BPC-157 charged?
Net negatively. Three acidic residues (Glu2, Asp10, Asp11) against one basic (Lys7).
Is it structured or flexible?
Both. Three consecutive prolines form a rigid polyproline segment; glycines provide flexible hinges around it.
Does it need a reducing agent?
No. There is no cysteine in the sequence.
Continue researching
Peer-reviewed guides, comparators and matched reference materials.
Primary sources & clinical trials
Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.
- PubChemPubChem · BPC-157 (CID 9941957)pubchem.ncbi.nlm.nih.gov
- PubMedSikiric P et al. Curr Pharm Des 2011 (PMID 21548867)pubmed.ncbi.nlm.nih.gov
- PubMedSikiric P et al., Fistulas Healing: Stable Gastric Pentadecapeptide BPC 157 Therapy. Curr Pharm Des 2020 (PMID 32329684)pubmed.ncbi.nlm.nih.gov
- PubMedKrivic A et al., Achilles detachment in rat and stable gastric pentadecapeptide BPC 157. J Orthop Res 2006 (PMID 16583442)pubmed.ncbi.nlm.nih.gov
- PubMedCerovecki T et al., Pentadecapeptide BPC 157 improves ligament healing in the rat. J Orthop Res 2010 (PMID 20225319)pubmed.ncbi.nlm.nih.gov
- PubMedSeiwerth S et al., BPC 157 and blood vessels. Curr Pharm Des 2014 (PMID 23782145)pubmed.ncbi.nlm.nih.gov
- GuidelineGoogle: Creating helpful, reliable, people-first contentdevelopers.google.com
Browse the wider literature
Live database searches, not fixed citations. Results change as new work is indexed.
Written and reviewed by
William Heath · Editor, UK Peptides research library
William Heath edits the UK Peptides research library. He is responsible for what is published here: every article is sourced to primary literature, every purity or identity statement traces to a signed third-party certificate for a specific lot, and corrections are made in place with the review date updated. No scientific or medical credentials are claimed on this site; the evidence is carried by the cited sources and the certificates, not by the byline.
More BPC-157 (Pentadecapeptide) articles
- Pentadecapeptide: The Word and What It Tells YouPenta-deca-peptide is fifteen. Where BPC-157 sits on the spectrum from short peptide to protein, and why fifteen residues is a useful size.
- What Does BPC-157 Stand For?BPC is body protection compound; 157 is a series designation with no chemical meaning. Why the name is a claim and where it came from.
- Body Protection Compound: A Name That Is a HypothesisThe name records what the Zagreb group believed they had found. What that framing asserts, and how to read a compound named for a proposed function.
- The Gastric Juice OriginBPC-157 is a partial sequence of a protein identified in human gastric juice. What that means, and what it does not mean about the peptide itself.
- The Stability Claim, ExaminedThe literature calls it the stable gastric pentadecapeptide. What stability means here, what supports the claim, and what it does not imply.